Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Chronic Dizziness
Interventions
DEVICE

SpotOn's corrective elements for dizziness

Eyeglasses with dizziness correction elements (real SpotOn eyeglasses) or eyeglasses with placebo (sham eyeglasses) elements will be worn during the whole four weeks study period.

DEVICE

Placebo

Trial Locations (1)

44281

Dept Neurology, Meir Medical Center, Kfar Saba

Sponsors
All Listed Sponsors
collaborator

SpotOn Therapeutics Ltd.

INDUSTRY

lead

Meir Medical Center

OTHER